ArticleClinical pharmacology and therapeutics2026

Population Pharmacokinetics and Exposure-Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis.

Benjamin Rich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.